PO017 CEREBRAL ANEURYSM IN KOREAN PATIENTS WITH TYPE 2 DIABETES MELLITUS

2014 ◽  
Vol 106 ◽  
pp. S54-S55
Author(s):  
J.T. Kim ◽  
Y.H. Ku ◽  
J.W. Yoon ◽  
H.K. Lee
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cerebral Aneurysm ◽  
Korean Patients

scholarly journals Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus

2015 ◽  
Vol 39 (4) ◽  
pp. 335 ◽  
Author(s):  
Hae Kyung Yang ◽  
Borami Kang ◽  
Seung-Hwan Lee ◽  
Hun-Sung Kim ◽  
Kun-Ho Yoon ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Korean Patients

The effect of rosiglitazone on serum lipoprotein(a) levels in korean patients with type 2 diabetes mellitus

Metabolism ◽  
2003 ◽  
Vol 52 (6) ◽  
pp. 731-734 ◽  
Author(s):  
Seung Hyun Ko ◽  
Ki-Ho Song ◽  
Yu-Bae Ahn ◽  
Soon-Jib Yoo ◽  
Hyun-Shik Son ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Serum Lipoprotein ◽  
Lipoprotein A ◽  
Korean Patients

scholarly journals Polymorphism in the HaeIII single nucleotide polymorphism of the SLC2A1 gene and cardiovascular disease in the early type 2 diabetes mellitus

2021 ◽  
Vol 18 (5) ◽  
pp. 147916412110412
Author(s):  
Dong-Hwa Lee ◽  
Gun Woo Won ◽  
Yong Hee Lee ◽  
Jong Sung Shin ◽  
Eu Jeong Ku ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Type 2 Diabetes Mellitus ◽  
Disease Duration ◽  
University Hospital ◽  
Korean Patients ◽  
Short Disease Duration ◽  
Slc2a1 Gene

Introduction: SLC2A1 polymorphism may play a role in the smooth muscle cell proliferation and extracellular matrix synthesis in vessels. However, the role of SLC2A1 polymorphism on diabetic cardiovascular disease (CVD) have not yet been identified. In this study, we aimed to investigate the association between SLC2A1 HaeIII polymorphism and CVD in Korean patients with type 2 diabetes mellitus (T2DM) according to disease duration. Methods: A total of 846 patients with T2DM who visited the Chungbuk National University Hospital were investigated. The HaeIII polymorphism of SLC2A1 gene was determined by real time polymerase chain reaction method. Genotyping results were presented GG, AG, or AA. Subgroup analysis was performed according to duration of T2DM (⩽10, 11–20, >20 years). Results: The AA genotype was significantly associated with higher prevalence of CVD in patients with DM duration less than 10 years (26.3% vs 9.2%, p = 0.014). There was no significant association between SLC2A1 HaeIII polymorphism and other diabetic complications including, retinopathy, nephropathy, neuropathy, cerebrovascular disease, and peripheral artery disease. Conclusions: The SLC2A1 HaeIII polymorphism was associated with CVD in Korean patients with T2DM with short disease duration.

Sign in / Sign up

Export Citation Format

Share Document